BOCA RATON, Florida,
March 6, 2018 /PRNewswire/ --
Vycor Medical, Inc. (OTCQB: VYCO) had
previously announced in October 2017
to its customer base the release of its enhanced VBAS, which it
would be slowly rolling out over the course of this year as it ran
down its inventory of the current VBAS. Following surgeon feedback
Vycor has decided that it will from now be shipping only the
enhanced model VBAS across the complete main range of 12 VBAS
sizes.
As previously announced the Company has been working on
improving how its VBAS integrates with the most common Image
Guidance System ("IGS") pointers on the market. The Company
believes that the enhanced VBAS model that is now being shipped
across the main range should make the use of a pointer more
intuitive and easy. This has involved molding a cup inside the
bottom end of the introducer part of the VBAS. The purpose of the
cup is to enable the pointer to be rested at the bottom of the
introducer without protruding through the hole at the tip, and also
help center the pointer in the device. The cup has been designed in
a way to ensure that the hole at the tip of the introducer still
allows fluids to pass into the device at sufficiently fast a rate
as to prevent the inadvertent build up of intra-cerebral pressure,
one of the original VBAS design parameters. The cup has been
positioned so as to minimize the offset of the tip of the pointer
and the outer tip of the introducer ensuring that the tip of many
of the common pointers is very close to the outer tip of the
device.
The next phase of development provides an alignment clip to keep
the IGS pointer aligned along the vertical access of the introducer
and will enable the securing of the IGS pointer so the surgeon will
no longer need to hold both the pointer and the VBAS. This second
phase is progressing and will be subject to regulatory
clearance.
Peter Zachariou the Company's CEO
said, "The changes we have rolled out will enable the VBAS device
to better accommodate the majority of pointers. Once the next phase
is completed, we believe we will have addressed most of the
feedback we have received from the market, and will have achieved
our objective of greatly improving how our VBAS device integrates
with IGS to facilitate seamless operation for surgeons."
About ViewSite™ Surgical Access System
Vycor Medical's ViewSite™ Surgical Access Systems (VBAS) is a
suite of clear cylindrical minimally-invasive disposable devices
that hold the potential for speedier, safer and more economical
brain surgeries and a quicker patient discharge. VBAS is
designed to optimize neurosurgical site access, reduce patient
risk, accelerate recovery and add tangible value to the
professional medical community.
The company is ISO 13485:2003 compliant, has U.S. FDA 510(k)
clearance for brain and spine surgeries and full regulatory
approvals for brain in Australia,
Brazil, Canada, China, Europe
(EU - Class III), Korea and Japan
and is seeking or has partial regulatory approvals in India, Russia, Taiwan and Vietnam. For an overview of Vycor Medical's
VBAS, see VBAS Video.
About Vycor Medical
Vycor Medical (OTCQB: VYCO) is dedicated to providing the
medical community with innovative and superior surgical and
therapeutic solutions. The company has a portfolio of FDA cleared
medical solutions that are changing and improving lives every day.
The company operates two business units: Vycor Medical and
NovaVision, both of which adopt a minimally or non-invasive
approach.
For the latest information on the company, including media and
other coverage, and to learn more, visit
http://www.vycormedical.com, http://www.vycorvbas.com or
http://www.novavision.com.
Contact:
Peter Zachariou
Tel. +1-561-558-2020
info@vycormedical.com
SOURCE Vycor Medical, Inc.